From March 11, 2024 to March 31, 2024, the company has repurchased 611,267 shares, representing 0.15% for CNY 17.01 million. With this, the company has completed the repurchase of 611,267 shares, representing 0.15% for CNY 17.01 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.13 CNY | -0.11% | -2.87% | -13.47% |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Tech Sector Galvanizes Asian Stock Markets | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.47% | 1.61B | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-12.13% | 33.49B | |
-20.48% | 14.62B | |
-9.91% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+4.12% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.